Rebecca has worked with ERP and MES systems and NN global supply chain for + 15 years. She was a business process specialist and super user of SAP, before she became a Solution Architect on a global ERP/MES implementation for all NN production sites (+20 sites). Currently, she is responsible for the direction and development of the MES Solution in NN as the MES Product Manager and System Architect and member of the leadership team in NN MES CoE. She is a member of BioPhorum’s MES of the Future work stream since 2022 and contributor to white papers regarding Interfaces and data. She is a passionate music lover, a mother of two, and hobby chef and visual artist.
I’m a visionary who is intrigued by the technological developments in the MES arena and how we in the industry can adopt and benefit from these developments. I’m a tech sceptic and I do not get swept away by tech fads as I want to understand and analyze how the adaptation can help us move forward. I’m fascinated by the human and organizational change that follows digitalization and technology transfer, and I’m passionate about enabling the human creativity by using IT and OT systems.
Panel Discussion
Monday, September 22
06:10 pm - 06:55 pm
Live in Berlin
Less Details
As pharmaceutical manufacturers face rising cost pressures, supply chain disruptions, and increasing demands for efficiency, the industry must rethink its approach to operational excellence. A holistic strategy—one that integrates innovative business models, digitalization, and resilient supply chains—is essential to navigating these challenges. From supply chain resilience in an era of geopolitical uncertainty to the role of new ownership models like Dynamic Shared Ownership (DSO), panelists will discuss how companies can optimize efficiency while remaining agile and competitive. In this session, you will learn more about: